We have estimated the cerebral protein syn thesis rates (CPSR) in a series of normal human volun teers and monkeys using L-[I-ll C]leucine and positron emission tomography (PET) using a three-compartment model. The model structure, consisting of a tissue pre cursor, metabolite, and protein compartment, was vali dated with biochemical assay data obtained in rat studies.
The rate of incorporation of an amino acid into proteins in the brain is indicative of the cerebral protein synthesis rate (CPSR) relative to the abun dance of the labeled amino acid. We have employed L-[I-11C]leucine with dynamic positron emission to mography (PET) imaging to generate estimates of the incorporation rate of exogenous leucine into protein in a series of normal humans, nonhuman primates, and rodents. With the knowledge of the leucine fraction relative to the total amino acid con tent of proteins in the brain, one can relate the incorporation rate of leucine to the CPSR. For con venience in this paper, the incorporation rate of leu cine is referred to as CPSR.
As discussed by Keen et ai. (1989) , L-[I-IIC] leucine labeled at the carboxyl position, as pro-about 0.5 nmoUmin/g agree well with hemispheric esti mates in monkeys. The sampling requirements (input function and scanning sequence) for accurate estimates of model parameters were investigated in a series of com puter simulation studies. Key Words: Cerebral protein synthesis rate (CPSR}--L-[I-ll C]leucine-Positron emis sion tomography (PET). posed by Sokoloff and colleagues (Smith et aI., 1980; Sokoloff and Smith, 1983) , is an ideal choice for estimation of cerebral protein synthesis with PET because of the rapid clearance of the l IC label that results from leucine metabolism, an alternative to incorporation into proteins. Leucine metabolism is initiated by reversible transamination with a-ketoglutarate to form a-ketoisocaproate, fol lowed by oxidative decarboxylation in mitochon dria (Chaplin et aI., 1976; Williamson et aI., 1979) . This process results in the generation of labeled CO2, which is then removed from the tissue by dif fusion and cleared from the blood by the lungs. Comar et ai. (1976) labeled methionine in the methyl group with IIC. Kinetic studies with l 1C _ methionine by Bustany et ai. (1983 Bustany et ai. ( ,1986 as well as nonkinetic imaging studies have indicated that this agent is also potentially useful in evaluation of amino acid kinetics and as a marker for conditions associated with high levels of methionine uptake, such as brain tumors and lung tumors (La France et aI., 1987; Kubota et aI., 1985) . However, transfer of the IIC label in methionine via S-adenosylmethio nine results in labeling of a variety of products that are retained in the brain. Therefore, the kinetic es timation of the incorporation of the label into pro teins, as distinct from metabolites, is not as well defined as it is for L-[l-l 1C]leucine.
As shown by Keen et al. (1989) using L-[1 _ 14C] leucine in rats, the distribution of the label from exogenous leucine can be divided into three princi pal compartments: a precursor compartment, a metabolite compartment, and a protein compart ment. The compartmental model employed in this study for the evaluation of CPSR consists of three compartments determined in rat studies. The model configuration was first suggested by Smith et al. (1980) and is based upon the assumption that a sin gle precursor pool directly supplies the protein and metabolite compartments. Our results support this model structure. The model is consistent with mea sured kinetic data, and predictions based on the use of the model agree well with direct chemical assays.
We have examined this model in a series of stud ies in normal humans and animals and have evalu ated the impact on the results of including a vascu lar term in the model. We also performed a series of computer simulations to investigate the sampling requirements (imaging frequency and duration) re quired to generate reliable estimates of the local cerebral protein synthesis rates (lCPSR).
METHODS AND MATERIALS

Animal studies
The methods and results of the tissue assay technique employed in the rodent studies are described in detail by Keen et aI. (1989) . Three rhesus monkeys were also in jected with approximately 15 to 30 mCi L-[l-lI C]leucine with a slow infusion and imaged in the NeuroECAT to mograph (Hoffman et aI., 1983) in the low resolution mode [image full width at half-maximum (FWHM) of 1l.5 mm] with a sequence beginning with 90 s scans and progressing to 10 min scans extending over a 2 h interval. All tomographic studies were performed with scanning levels parallel to the canthomeatal line. The three-plane mode of operation of the N euroECA T was employed with the central plane approximately at the level of the basal ganglia.
The monkey input function measurements (obtained from arterial cannulas), metabolite corrections, and plasma leucine measurements were performed analo gously to the human studies described below. Tissue time-activity data were generated from hemispheric re gions of interest.
Patient population
Nine normal human volunteers were studied. All sub jects signed informed consents and the study protocol was approved by the UCLA Human Subject Protection Committee. Seven of the subjects were carbohydrate loaded prior to the study and two were fasting for 8 h prior to the study. Carbohydrate loading consisted of a carbohydrate meal 1 to 2 h before the study and a sup-plement of oral glucose approximately 30 min prior to the study. Two of the fed subjects had the carbohydrate meal without the additional glucose.
Preparation of L-[l-ll C]leucine
L-[I-II C]leucine was prepared using an immobilized D amino acid oxidase (coimmobilized with catalase) as pre viously described by Barrio et aI. (1983) . The product is chemically and radiochemically pure (>99%) and pyro gen free.
Blood sampling
Following L-[I-II C]leucine lllJection, 2-ml arterial blood samples (obtained with a radial artery catheter) were obtained at approximately 5-10 s intervals for the first 2 to 3 min of the study and at progressively length ening intervals thereafter. Plasma samples were extracted from the blood samples through centrifugation and were counted in a NaI well counter. Labeled II C02 (which accounted for a negligible fraction of the total activity in the plasma) was removed from plasma by acidifying the plasma samples with 5% perchloric acid. Additionally, separate arterial blood samples were obtained at approx imately 15 min intervals for chemical assay of the distri bution of the II C label between leucine and plasma pro teins. Two additional samples were obtained during the study for measurement of the unlabeled leucine concen tration. These chemical assay procedures are described in detail by Keen et aI. (1989) .
The metabolite corrected plasma time-activity curve (input function) was generated from the total II C activity measured in plasma as a function of time using the frac tional distribution (between leucine and other products) of II C in plasma. These corrections were applied using linear and modified exponential fits to the measured frac tional distribution data from individuals and from the en tire subject group in humans. These methods, as well as those applied in rats and monkeys, are described in more detail below.
Scanning sequence
Patients were injected with 20 mCi intravenously using either a slow bolus over about 1 min or a more rapid bolus over about 30 s. Images were obtained on a NeuroECAT tomograph (Hoffman et aI., 1983) in the low resolution mode (image FWHM of 11.5 mm) with a scan sequence consisting of six I-min scans, six 2-min scans, six 5-min scans, and six lO-min scans for a total scan duration of 108 min scanning time and about 110 min in total elapsed time. In some subjects, initial scans of 2-min duration were used. Three scans parallel to the canthomeatal line were obtained. The center scan was approximately at the level of the basal ganglia. Figure 1 illustrates the compartmental model configu ration used in this study. The rate constants kl and k2 describe forward and reverse transport of leucine across the blood-brain barrier, respectively, while k5 represents incorporation into proteins, and k3 and k4' respectively, represent incorporation into the metabolic compartment and clearance of the label in the form of II C02• The ra dioactivity in the vascular compartment is represented by a separate parameter k6 as described below [Eq. (9) ]. The transport processes of the labeled tracer are assumed to be first-order.
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Compartmental model configuration, illustrating the three tissue compartment C 1 (precursor), C2 (metabolite), and C3 (protein). The rate constants k 1 and k2 refer to forward and reverse transport of leucine across the blood-brain bar rier, respectively; k3 and k 4 are rate constants for incorpora tion into and release from the metabolite compartment, re spectively; and ks is the rate constant for incorporation into the protein compartment.
If the concentrations of tissue precursor, metabolite, and protein compartments are, respectively, denoted by G I , Gz, and G3 ( Fig. 1 ) and the metabolite corrected plasma leucine concentration as a function of time (input function) is Gp(t), then C1 = k1Gp(t) -(k2 + k3 + kS)G1 (t)
The solution of the above differential equations (assum ing that initial concentrations are zero) is where * indicates the operation of convolution.
However, the total activity Gj(t) is simply a sum of the three compartments GI, Gz, and G3 • Therefore,
The instantaneous tissue activity concentration as a function of time is given by 
Adding a vascular compartment term to the model yields (9) where k6 represents the vascular volume in tissue. Gp y (t) represents the measured input function of the total I C activity in plasma, uncorrected for the distribution of the label between leucine and proteins. The total II C radio activity concentration in whole blood is assumed to be approximately equal to that in plasma.
The scan data actually represent, of course, the inte grated value of Gj(t) over the duration of each scan:
where Gj nt is the observed scan measurement for a scan with midtime T and start and end time TI and Tz, respec tively. Therefore, the model parameters kl , kz, k3 , k4, k5, and k6 can be estimated iteratively from the measured input function Gpu(t), the metabolite corrected input function G , (t), and tissue time-activity curve (from image regions o interest) using Eqs. (8) (with no vascular compartment) and (9) (vascular compartment included) modified to in clude an integration factor as described in Eq. (10). Equa tion (8), corrected for the scan integration factor de scribed in reference to Eq. (10), is referred to as the five parameter model in this paper while Eq. (9), also corrected for the scan integration factor, is termed the six-parameter model.
Assuming no labeled protein breakdown and that an equilibrium state has been reached, the distribution vol ume (DV) of free leucine in tissue is given by (11) Therefore, because the distribution volume represents the equilibrium tissue vs. plasma concentration of leu cine, the tissue (precursor) concentration of leucine is
However, the protein synthesis rate (amino acid incorpo ration rate) is simply the forward flux of incorporation into the protein compartment. The cerebral protein syn thesis rate (CPSR) is thus the tissue leucine concentration (precursor concentration) multiplied by the rate constant k5:
The term kl k5/(kz + k3 + k5) is referred to as KpSR in discussions below. Because both the protein incorpora tion step and the metabolic pathway stem from the same precursor pool, the ratio of CPSR to amino acid (AA) metabolism is a ratio of the respective fluxes from the precursor pool (the respective rate constant multiplied by the compartmental concentration). The compartmental concentrations cancel, yielding CPSR k s AA metabolism k3 (14) The half-times of turnover of the tissue leucine (precur sor) and metabolite compartments are given by 0.693
Estimation of model rate constants
Equations (8) and (9) can be used as the basis for pa rameter estimation using least squares regression. In or der to facilitate incorporating the scan integration factor [Eq. (10)] into the model, either Eqs. (8) and (9) can be modified to include the integration factor directly, analo gously to the approach used by Hawkins et ai. (1986) for the fluorodeoxyglucose (FDG) method, or the following approach implemented by Huang et ai. (1986) for studies of oxygen metabolism with PET can be employed.
Equations (1)-(3) form a system of simultaneous differ ential equations that can be represented in the following standard form (Chen, 1970) :
In addition to C I' C 2' and C 3' a fourth differential equa tion representing the rate of change of the time-integrated tissue radioactivity concentration [Cin,(t)), rather than the Then, X(f) is a column vector consisting of C I (f), C2(f), C3(t) , Cint(t); B is the column vector kl' 0, 0, 0; Vet) is Cp(f); Y(t) represents the tomographic measurement; Cis a row vector [0,0,0,1]; and
Equation (17) can then be solved (Huang et aI., 1986 ) and fit to the measured tissue time-activity curves to es timate the parameter kl' k2' k3' k4' ks, and k6• This data processing is facilitated with the software package BLD (Carson et aI., 1981) .
RESULTS AND DISCUSSION
Animal studies
Rats Keen et al. (1989) measured the time course of tissue concentrations and specific activities of leu cine, leucyl-tRNA, labeled protein, and leucine me tabolites, specifically a-ketoisocaproic acid (KIC) and 14C02 in a series of rats at time intervals from 2 to 35 min after injection of L-[1-14C]leucine.
Once labeled leucine crosses the blood-brain bar rier and enters the tissue leucine space, it will either undergo metabolism as described above or, after association with tRNA to become leucyl-tRNA,
FIG. 2. Model fit to chemically
assayed L-[1-1 4 Clleucine data in rat brains. The plasma time activity curve (metabolite cor rected) was used as the input function. Radioactivity in the protein (C3) and metabolite (C2) compartments were considered as the observations in the fit ting. The upper smooth line and filled squares represent the model fit and measured radio activity, respectively, in the pro tein compartment while the lower smooth line and filled squares represent the model fit and measured radioactivity in the metabolite compartment. The filled circles represent the measured radioactivity in the precursor compartment (C 1 ) while the dashed line repre sents the model predicted val ues in this compartment. The measured values in the precur sor compartment agree well with the model predicted val ues. (rYiin) will be incorporated into protein. Because the amount of leucyl-tRNA in tissue is small compared to leucine or proteins in tissue, the majority (>99%) of the 14C label in tissue will be associated with either free leucine, tissue proteins, or leucine me tabolites. Only a negligible fraction will exist in the form of labeled leucyl-tRNA. Therefore, the labeled leucine in tissue, measured directly, as described by Keen et al. (1989) , will represent a direct assay of radioactivity in the precursor compartment of the model presented in Fig. 1 . This together with mea surements of the total activity of metabolites (KIC and COz) and protein in tissue represent direct mea surements of the radioactivities in compartments C 1 , Cz, and C3, respectively, in Fig. 1 .
As discussed by Keen et al. (1989) , measurement of CPSR with exogenously administered labeled leucine results in an estimate of the exogenous CPSR only, not the total CPSR. The total CPSR will reflect protein synthesis originating from both ex-ogenous and endogenous amino acids. A tracer method such as that described in this work pro duces a kinetic description of the labeled substrate (L-[1-11C]leucine) from an exogenous source but does not permit an analysis of unlabeled endoge nous pools of leucine.
If the metabolite-corrected input function and the total (C1 + Cz + C3) tissue activity are determined, the model parameters k l -k5 can be estimated as de scribed in the Methods section. The vascular term can be neglected in rats because the cerebral blood volume (CBV) in the decapitated animal is very small. Alternatively, rather than using total tissue activity as the observation, the observation can be defined as the concatenated set of measurements of C 1 , Cz, and C3• This has the effect of increasing the number of data points and leads to convergent so lutions with fewer discrete sampling times than used in human kinetic PET studies. Additionally, with animal tissue sampling data, the measurements a Individual linear metabolite correction to input function (see the text). b Group linear metabolite correction to input function.
C Group linear/exponential metabolite correction to input function.
d Results from tissue sampling data from rats as described in text and by Keen et al. (1989) .
e Hemisphere results in monkeys using individual linear metabolite corrections to input functions.
represent instantaneous, rather than integrated, ob servations. Therefore, no scan integration factor needs to be incorporated into the parameter estima tion process. The model is identifiable (unique values for the parameters are generated) using any of the follow ing three types of data sets: (a) metabolite-corrected input function and total tissue time-activity (C1 + C2 + C3) data (PET approach); (b) metabolite corrected input function and direct measurement of C1, C2, and C3 as described above; or (c) metabo lite-corrected input function and direct measure ment of C2 and C3• Approach (c) above was applied to the rat data and the model-predicted concentration of precursor compartment C 1 was found to agree well with direct measurement. Figure 2 represents the results of ap proach (c) in the rat data. The tissue data represent the average of results in three animals per time point. The input function used in the fitting process represented a composite generated from 10 animals. Note the very good correspondence between the model predicted and the actually measured values in the precursor C1 compartment, confirming the validity of this compartmental structure. The model parameters estimated are shown in Table 1 . Both approaches (b) and (c) yielded the same values for the model parameters, as expected. The estimated CPSR of 3. 4 nmollminlg in rats agrees well with the directly measured value of the rate of incorporation of exogenous leucine (CPSR) of 3. 2 nmol/minlg ob tained by direct tissue assay techniques in the same animals (Keen et aI., 1989) . Table 1 lists the parameter estimates and CPSR value as well as the half-times of turnover for the precursor and metabolite compartments for hemi spheric monkey data. Only the five-parameter model was applied to the monkey data. Note the half-times of turnover of the precursor and metab olite compartments, and CPSR is very similar to the human hemispheric data using the five-parameter model with linear corrections to the input function. These input function corrections are described in more detail below. Additionally, the individual rate constants are quite similar.
Monkeys
While K P SR is somewhat lower in the monkey compared to the human studies (0.00309 mllminlg compared to 0.00568 mllminlg for the group linear five-parameter model), this was compensated for by a higher average plasma leucine concentration in monkeys (184.6 ± 59.4 nmol/ml) compared to hu mans (107. 2 ± 39.9 nmollml), resulting in very sim ilar CPSR values (0.5478 nmollmin/g in monkey hemispheres and 0.5266 nmollminlg in human hemi spheres with a five-parameter model and a group linear metabolite correction; see Table 1 ).
Human studies
Plasma leucine concentrations
The average value for plasma leucine concentra tion in the nine subjects imaged in this study was 107. 2 ± 39. 9 nmol/ml. This agrees well with a pub lished average value of 100, with a range of 71-175 nmol/ml for normal adults (Rosenberg and Schriver, 1980) .
As described in the Methods sections, the input functions in the kinetic studies were corrected for the accumulation of IIC in plasma proteins [see Keen et al. (1989) ]. Figure 3 represents a plot of the percent \ l C label associated with leucine relative to total \ l C plasma radioactivity as a function of time in 11 normal volunteers. Linear regression analysis yielded a correlation coefficient of 0.94. Other func tional fits to this distribution data are possible. The five-and six-parameter models applied to hemi spheric data were fit using three different forms of metabolite corrections to the input functions, in cluding linear fits using individual patient data in each study, linear fits using the group data illus trated in Fig. 3 , and a combination linear/ exponential fit assigning a value of 100% to the leu cine fraction up to 20 min and employing a single exponential fit to the data thereafter in the group data. Because of the similarity of the results for the group linear vs. individual linear input function cor rections (see Table 1 ), the gray and white matter data were all processed with the group method. The linear/exponential fit method produced a higher CPSR value than the other two methods for the five-parameter model while the results were com-3 2 3 2 parable with all three methods in the six-parameter fits. The addition of the sixth parameter tends to blunt the effect of the correction method applied to the input function. Figure 4 is an example of PET images from a normal L-[1-\ l C]leucine study in a human. The im ages reflect both less contrast between gray and white matter and a lesser image quality than for images obtained with 2-deoxy-2-[18F]fluoro D-glucose (FDG). This is consistent with the rela tively low count rate in a IIC leucine CPSR study compared to an FDG study. This is the expected result given the much lower rate of protein synthe sis (approximately 0.5 nmol/min/g, see Table 1 ) in the brain compared to the rate of glucose metabo lism (approximately 0. 3 j.Lmol/min/g) (i.e., a factor of approximately 1,(00). Additionally, the relatively long turnover half-time for the metabolite compart ment (approximately 20 min in hemispheres, Table  1 ) requires a scanning time sufficient to permit a kinetic distinction between leucine incorporation into proteins as opposed to its oxidation and metab olite (C02) release from tissue.
Kinetic estimates in normal controls
As discussed by Phelps et al. (1984) , a rapid turn-1 1 FIG. 4 . Representative composite images of 11C radioactivity distribution in normal brain obtained from 10 to 30 min after injection of L-(1-1 1Cjleucine. The images are unsmoothed (above) and smoothed (below) at three different levels through the brain, approximately at the level of the centrum semiovale (left), basal ganglia (center), and petrous pyramids (right).
over time of the precursor pool, relative to the half time of the label, is desirable to insure reasonable uptake into the protein compartment within the study period. The half-times of turnover of the pre cursor compartment in this study, in the range of 1 to 3 min (Table 1) , satisfies this requirement. The half-time of turnover of the metabolic compartment of about 20 to 30 min (Table 1) indicates that a sig nificant amount of clearance of activity from this source will occur with examination periods on the order of 60 min. Figure 5 illustrates the relative distribution of the ll C label between the precursor, metabolite, and protein compartments predicted by the model using a five-parameter fit to hemispheric regions of inter est in a normal human. Note the progressive accu mulation of activity in the protein compartment. Af ter approximately 40 min, the majority of the tissue activity is in this compartment. Table 1 lists the values for the model rate con stants for the five-and six-parameter models, Kp SR ' CPSR, and the turnover half-times for the precursor and metabolism compartments for hemi spheres and gray and white matter using the various forms of metabolite corrections for the input func tions described above.
Addition of the vascular parameter to the model decreased the values of the forward and reverse transport rate constants (k1 and k2' respectively) significantly but had little effect upon k3' k4' and ks.
The CPSR is decreased significantly in the six parameter results compared to the five-parameter results (e.g., in hemispheres the decreases were 16.9 and 23.3% for individual and group linear input function corrections, respectively). Of particular interest is the significant increase in CPSR in hemispheres with the linear/exponential correction to the input function compared to the linear form with the five-parameter model (an in crease from 0. 5266 to 0. 6138 nmol/min/g). This in dicates a relatively high sensitivity of the five parameter model to the method of metabolite cor rection that is less evident in the six-parameter results. In our subjects, while the individual and group linear input function corrections yielded sim ilar results as a group, the coefficients of variation of the CPSR estimates were slightly smaller for the group, as opposed to the individual corrections, for both the five-and six-parameter models (32 vs. 50% for the five-parameter model and 43 vs. 55% for the six-parameter model), indicating a potential advan tage for the group correction method in terms of stability of the estimates. Table 1 indicates that the measured CPSR values in gray matter and hemispheres are comparable while those in white matter were somewhat lower. The values for white matter must be interpreted with caution for several reasons, including the rel atively poor definition of white matter regions of interest and the lower radioactivity level in these regions. Both of these factors were probably re sponsible for the fact that convergent fits to both five-and six-parameter models could only be ob tained in five of the nine subjects in representative white matter regions (in some subjects one, but not both, methods produced convergent results and these were not included in Table 1 ).
While no comparative values of CPSR in humans are available, hemispheric CPSR values of about 0.5 nm/min/g were obtained for both humans and time (min) monkeys (five-parameter model) in this study. Ad ditionally, given the good agreement between the results for CPSR obtained kinetically and by direct tissue assay in the rat studies, the model configura tion appears to be appropriate. The higher values of CPSR obtained in rat brain (about 3 nm/min/g), rel ative to the human and monkey, is not surprising given interspecies differences and the generally higher rates of many physiological processes in smaller animals relative to larger ones (Boddington, 1978; Boxenbaum, 1982) . However, as discussed earlier, the CPSR measurement obtained with a tracer amount of labeled leucine only reflects the CPSR from exogenously supplied amino acids. The relationship between this exogenous CPSR and the total CPSR in tissue is dependent on whether there are separate pools for exogenous and endogenous leucine (or leucyl-tRNA). More biochemical studies are needed to characterize better the pool sizes and fluxes of endogenous leucine before one can formu late strategies to estimate total CPSR in tissue with PET.
Five-vs. six-parameter model
Two model configurations were presented above: the five-parameter (without a vascular term) and six-parameter (with vascular term) models. The six parameter model is more physiologically compre hensive and, as we have previously shown with ki netic FDG studies, should reduce error (overesti mations of CPSR) introduced by ignoring the high intravascular concentration of L-[I-ll C]leucine early after the injection. Alternatively, the impact of intravascular activity can be minimized in model configurations without a vascular space by ignoring data points obtained early after the injection (i.e., by using an appropriate weighting function in the regression process). Figure 6 is an example of a normal hemispheric region of interest fit with a five-parameter weighted model (points prior to peak in time-activity curve are weighted zero), a five-parameter unweighted model (all data points used and weighted equally), and a six-parameter model (all data points used and weighted equally). The five-parameter weighted and six-parameter models typically fit the data well. The five-parameter unweighted model did not (of ten no convergence was obtained).
In most regions of interest, both the five-and six-parameter models converged. Therefore, the choice between model configurations can be based primarily on biological considerations and the six parameter model is generally preferred. However, the five-parameter weighted model did tend to con verge to solutions more rapidly than the six parameter model. The five-parameter model results listed in Table 1 all represent the results of weighted fits, as described above.
Dietary preparation
Because leucine may either be incorporated into protein or be metabolized via transamination [Fig. 12, Keen et al. (1989) ], the dietary preparation of the subject may affect the relative distribution of the labeled L-[1-l IC]leucine between these alterna tive pathways, as discussed in detail by Keen et al. (1989) .
The hemispheric ratio of protein synthesis to me tabolism (k5/k3) declined from 0.445 ± 0.215 in the seven fed subjects (see the Methods section for de-
scription of dietary preparation) to 0.204 ± 0.141 in the two fasted subjects using the six-parameter model with group linear metabolite correction, and from 0.515 ± 0.172 to 0.286 ± 0.176 with the five parameter group linear metabolite correction method. While these declines did not achieve sta tistical significance, the trend is consistent with a relative shift of amino acid utilization to metabo lism, as opposed to protein synthesis, in a fasted state. This result suggests a strategy of carbohy drate loading in preparation for PET studies (Phelps et aI. , 1984) . 
Simulations
Study Duration (min )
Study Duration (min) J Cereb Blood Flow Me/ab, Vol. 9, No.4, 1989 from kinetically determined model parameters (rate constants). In order to identify the minimum amount of time required to achieve stable parame ter estimates, we generated a set of tissue curves with Eq. (17), using a set of rate constants from a normal control. A standard scan sequence (see the Methods section) was used, beginning with a total scan time of 108 min and then progressively short ened by dropping individual scans. With noise-free data, stable and reproducible parameter estimates with total acquisition times as short as 20 min were obtained. Since noise was added to the data, the total time required to achieve stable parameter es timates progressively increased. Figure 7 is a plot of the coefficient of variation of individual parameter estimates (six-parameter model) for simulated tis- from hemispheric data from a normal control fit over a range of total acquisition times. The v alues for parameters k 1 through ks for the full acquisi tion sequence were, respec tively, 0.0257 ml/min/�, 0. 2713 min-l, 0.0750 min-, 0.0421 min-1 , 0.0376 min-1 , and 0.0169 ml/g. The values for the coefficients of variation for the full acquisition sequence for pa rameters k 1 through ks were, re spectively, 0.0462, 0.1011, 0.1435, 0.0944, 0.0822, and 0.054 3. Below approximately 40 min of total scan time, a significant loss of parameter accuracy occurs. A similar pattern of results for individual parameters was found for the five-parameter model. Figure 8 illustrates the coefficients of variation from hemispheric data from a normal volunteer fit over a range of acquisition times. The parameter values stabilize with low coefficient of variation with total scan times of about 40 min or more, in good qualitative agreement with the simulation de scribed above. Noise was added to the data. Note the relative stability of pa rameter values and coefficients of variation with initial duration up to about 2 min. Values of the parameters k 1 through k6 used in the simulation were, respec tively, 0.0257 ml/min/g, 0.2713 min-1 , 0.0750 min-1 , 0.0421 min-1 , 0.0376 min-1 , and 0.0169 ml/g.
The stability of the parameter estimates over a fairly wide range of acquisition times is consistent with a plot of the sensitivity functions for the indi vidual model parameters shown in Fig. 9 . The sen sitivity functions for each parameter Sj indicate the degree of change of the tomographic measurement for a change in parameter kj and are defined by
where Y(t) represents the tomographic measure ment as described in reference to Eqs. (17) and (18). The plots are based upon Eq. (20) and illustrate
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that the largest effect of changes in the model pa rameters is early in the acquisition sequence when intravascular activity is rapidly changing. This is particularly true for the vascular term (k6), whose sensitivity function parallels the shape of the input function. The sensitivity functions for k] and k2 also change relative rapidly during this period, while at later times the sensitivity functions for all parame ters changed only gradually. The sensitivity func tions for the five-parameter model were similar, with the absence of the sixth term.
Effect of initial scan frequency
Another scanning parameter of interest is the ini tial scan frequency required to produce accurate parameter estimates. We performed a series of sim ulations to evaluate the effect of varying the initial scan time during the first 3 min of the dynamic im aging sequence. During this period (immediately following injection), the intravascular activity changes rapidly and the model parameters for for- ward and reverse transport and for the blood vol ume term in the six-parameter model should be re lated to the initial scan frequency. Figure 10 illustrates the effect of varying the ini tial scan duration from 6 s to 3 min during the initial 3 min of a dynamic study. The remainder of the study was acquired with a standard acquisition se quence (see the Methods section). In this simula tion, noise was added, and the results for the six parameter model were plotted. The results indicate that reliable parameter estimates with low coeffi cients of variation are possible with initial scan du ration up to about 2 min. The results were similar with the five-parameter model.
Nonsimultaneity of tissue data and peripheral arterial input
As we have previously discussed for PET kinetic studies with FDG (Hawkins et aI. , 1986) , one of the assumptions implicit in many models is that the in put function measured directly from a peripheral FIG. 11. Effect of timing delay between input function measured at peripheral arterial site and arrival at cerebral capillary. a and b illustrate the parameter values and coefficients of variation for 6 s initial scans and c and d are the corresponding values for 2 min initial scans. Note the change in scale on plots band d. Parameter values used in the simulation for k1 through ks were, respectively, 0.0257 milmin/g, 0.2713 min-1, 0.0750 min-1 , 0.0421 min-1 , 0.0375 min-1 , and 0.0169 ml/g. artery (e.g., radial artery) represents the true input function at the brain capillary. Independent of con centration gradient effects across the capillary that require a distributed modeling approach to address, the arrival of an intravenously injected bolus of ac tivity in a peripheral artery will in general not coin cide with the arrival at the brain capillary. While this difference in arrival times can be corrected by direct measurement of the difference in arrival times or included as an additional parameter in the model, such corrections are not convenient to per form in practice. In order to test the adequacy of ignoring this time delay of this work, we performed a series of simulations with a range of timing delays incorporated into the data. Figure II illustrates the effects of increasing the delay of the peripherally measured input function, relative to the arrival of the bolus of radioactivity in the cerebral capillary, from 0 to 30 s for a series of scan sequences with initial scan durations of 6 s to 2 min. In this simulation, noise-free data were em ployed in order to isolate the effects only to the delay.
With increasing delay, all scan sequences pro duced progressively increasing errors in the param eter values (particularly k2 and k3) and progressively increasing coefficients of variation of the individual parameters. Note, however, that the increase in the coefficient of variation is less pronounced with larger initial scan times and that with initial scan times of 1-2 min, the coefficients of variation are low and the parameter values are reasonably con stant even with delays larger than 6 s. The effect of the delay upon the macroparameter KpSR [k1k5!(k2 + k3 + k5), see Eq. (13)] is even less pronounced than for the individual k values, as shown in Fig. II. 
CONCLUSIONS
The L-[I-llC]leucine kinetic PET method for measurement of CPSR produces regional estima tions of protein synthesis from an exogenous source of amino acids. In simulations and studies in control subjects, initial scan durations of I to 2 min with a total study duration of I h or more are sufficient to produce convergent solutions to the model in nor mal tissue.
Based upon the results in our control subjects, the preferred model configuration is a six-parameter model. Further studies are needed to test the sen sitivity of the method relative to the correction method applied to the input function.
The model structure, consisting of a tissue pre cursor compartment, a metabolite compartment, and a protein compartment, is supported by animal studies (Keen et aI., 1989) . Potential applications of this method include estimation of CPSR during de velopment, following brain injury, and in cerebral neoplasms.
